Abstract
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease that is characterized by the destruction of insulin-producing beta-cells in the pancreatic islets. A single administration of CFA prevents clinical hyperglycaemia in non-obese diabetic (NOD) mice. We have previously shown that CFA administration does not eliminate insulitis in the pancreas of the treated animals, but diverts the disease process from a destructive to a non-destructive pathway. We provide evidence that this phenomenon may be under cytokine control. Neutralizing monoclonal antibodies against IL-4 and IL-10 were injected, singularly or in combination, into CFA-treated NOD mice. Antibody treatment did not lead to the development of overt diabetes; however, a marked impairment of glucose tolerance was shown in about one half of the mice treated with a combination of the two antibodies at the end of the study. This functional abnormality correlated with the histological loss of pancreatic islet tissue. These studies suggest a role for IL-4 and IL-10 in CFA-induced protection from diabetes in the NOD mouse. They also suggest that, in this animal model, the nature of the autoimmune response to islet tissue (either destructive or non-destructive) may ref...Continue Reading
References
Jun 1, 1992·Immunological Reviews·A SherH C Morse
Jun 1, 1992·Immunological Reviews·C A Dinarello
Jan 1, 1992·The Journal of Experimental Medicine·J S SilvaS G Reed
Oct 1, 1991·The Journal of Pathology·A K FoulisM A Farquharson
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·F P HeinzelR M Locksley
Apr 1, 1991·Journal of Autoimmunity·M Debray-SachsJ F Bach
Aug 4, 1990·Lancet·F NicolettiC Zanussi
Aug 4, 1990·Lancet·P Lumbiganon, C Wasi
Jun 1, 1991·Diabetes·M F McInerneyD W Thomas
Aug 30, 1990·Nature·N SarvetnickT Stewart
May 1, 1990·Diabetes·M W SadelainB Singh
Mar 11, 1988·Cell·N SarvetnickT A Stewart
Jan 1, 1989·Annual Review of Immunology·T R Mosmann, R L Coffman
Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
Apr 1, 1989·European Journal of Immunology·K BottomlyD B Murphy
Nov 1, 1987·The Journal of Experimental Medicine·H M CherwinskiT R Mosmann
Jan 1, 1985·Metabolism: Clinical and Experimental·J D WilsonS P Haynes
Sep 1, 1994·Diabetologia·C BoitardJ F Bach
Mar 19, 1994·Lancet·N ShehadehK J Lafferty
Apr 1, 1994·Diabetologia·P SempéC Boitard
Aug 1, 1994·Diabetologia·A RabinovitchR C Bleackley
Jun 25, 1993·Science·T A StewartN J MacLachlan
May 1, 1993·International Immunology·P SempéC Boitard
Jun 1, 1993·Journal of Autoimmunity·N N ShehadehK J Lafferty
Citations
Sep 20, 2002·The New England Journal of Medicine·Jean-Francois Bach
Mar 13, 2001·Annual Review of Immunology·J F Bach, L Chatenoud
Aug 14, 2009·American Journal of Physiology. Renal Physiology·Hye Ryoun JangHamid Rabb
Mar 20, 2010·PloS One·Sean P Stromberg, Jean M Carlson
Sep 29, 2005·Expert Opinion on Biological Therapy·Lucienne Chatenoud, Jean-François Bach
Nov 8, 2014·Diabetes·Subha Karumuthil-MelethilChenthamarakshan Vasu
Sep 10, 2008·Cytokine·Michael S StalveyTerence R Flotte
Nov 1, 2003·Annals of the New York Academy of Sciences·Jean-François Bach
Jan 21, 2006·Immunology·Thomas O Ola, Neil A Williams
Dec 28, 2002·Journal of Neuroscience Research·Yuval TalFelix Mor
May 4, 2001·Journal of Autoimmunity·J F Bach
May 25, 2016·Journal of Autoimmunity·Chantal KuhnLucienne Chatenoud
Apr 18, 2000·The Journal of Pathology·B A O'BrienD J Allan
Jun 24, 2004·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Jacob GeorgeArie Roth
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BotM von Herrath